Cargando…
Metformin - its anti-cancer effects in hematologic malignancies
The main anti-diabetic effect of metformin mediated through stimulation of adenosine monophosphate (AMP)-activated protein kinase (AMPK) is the inhibition of hepatic gluconeogenesis and triggering glucose uptake in skeletal muscles. Additionally, some new pathways, besides the AMPK activation, were...
Autor principal: | Podhorecka, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967492/ https://www.ncbi.nlm.nih.gov/pubmed/33747367 http://dx.doi.org/10.4081/oncol.2021.514 |
Ejemplares similares
-
Abnormal microRNA expression in the course of hematological malignancies
por: Szymczyk, Agnieszka, et al.
Publicado: (2018) -
Target Therapy in Hematological Malignances: New Monoclonal Antibodies
por: Podhorecka, Monika, et al.
Publicado: (2014) -
Prognostic significance of isochromosome 17q in hematologic malignancies
por: Koczkodaj, Dorota, et al.
Publicado: (2021) -
Addendum: Prognostic significance of isochromosome 17q in hematologic malignancies
por: Koczkodaj, Dorota, et al.
Publicado: (2023) -
The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies – A Narrative Review
por: Stefaniuk, Paulina, et al.
Publicado: (2020)